Learn how the Global Fund is tackling COVID-19 to protect progress on AIDS, TB and malaria, including the new COVID-19 Response Mechansim.
The COVID-19 pandemic is having a catastrophic impact on the most vulnerable communities worldwide and threatens progress against HIV, TB and malaria.
Subscribe to receive updates
The Global Fund to Fight AIDS, Tuberculosis and Malaria: A smart, lifesaving U.S. investment
U.S. investments in the Global Fund provide significant health security and economic benefits
Grows export markets
Catalyzes domestic investments in health
Helps contain emerging pandemics
Young Women at Risk
Growing Youth populations
Translating Progress into Success to End the AIDS Epidemic is a collaboration between amfAR, AVAC, and Friends of the Global Fight, with technical assistance from the Henry J. Kaiser Family Foundation. The report was conceptualized to take stock of how far we have come – and how far we have to go – toward ending HIV and AIDS around the world.
In 2019, the whole world stepped up, pledging $14 billion for the Global Fund’s hugely successful sixth Replenishment – an unprecedented 15 percent increase over the previous fundraising cycle. U.S. leadership was instrumental, encouraging other donors to increase their contributions and get the world back on track to end AIDS, TB and malaria.
The Global Fund to Fight AIDS, Tuberculosis and Malaria is the world’s largest global health funder and has saved 32 million lives since its founding in 2002. Below are just a few examples of how the Global Fund has helped scale innovative treatment, prevention and diagnostic technologies over the past 18 years.
How U.S. investments in the global fight to end AIDS, TB and malaria help prepare the world to identify and respond to emerging pandemics.LEARN MORE
The COVID-19 pandemic is having a serious impact on the most vulnerable communities worldwide and threatens progress on HIV, TB, malaria, vaccination and other areas of health. Below, you can find regularly updated information on the impact of COVID-19 on HIV/AIDS, TB and malaria and news items from around the world on important developments. 1….
Statement on Absence of Support for the Global Fund in Senate COVID-19 Supplemental WASHINGTON, D.C.— Statement from Chris Collins, President and CEO of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, on the absence of support for the Global Fund in the Senate COVID-19 Supplemental: “America will never be safe from COVID-19 if…
The Fatal Consequences of COVID-19 on AIDS, Tuberculosis and Malaria Global Fund Executive Director Peter Sands informed attendees of the 2020 International AIDS Society Conference of a grim reality surrounding COVID-19: “We face the really sobering prospect that if we do not mount an effective response, we could find ourselves losing maybe a decade’s worth…
On July 14, Friends of the Global Fight Against AIDS, Tuberculosis and Malaria hosted an online webinar to discuss the impact of COVID-19 on global HIV, TB, and malaria programs in Africa. The webinar highlights: 1. What we know from evidence and experience about the impact of COVID-19 on HIV/AIDS, TB, and malaria thus far,…
The Global Fund to Fight AIDS, Tuberculosis and Malaria: At the Leading Edge of the Global Response to COVID-19 The COVID-19 pandemic threatens to reverse extraordinary gains made in the fight against the epidemics of AIDS, tuberculosis and malaria. The United States should be proud of our leading role in addressing these epidemics but COVID-19…